Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors

Bibliographic Details
Main Authors:	N. Lopina, I. Dmytrenko, D. Lopin, D. Hamov, I. Dyagil
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137920301668

id	doaj-e2c2fdbe8ff64cafaa36133fea2dd05b
record_format	Article
spelling	doaj-e2c2fdbe8ff64cafaa36133fea2dd05b2020-11-25T03:57:36ZengElsevierHematology, Transfusion and Cell Therapy2531-13792020-10-01421819Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitorsN. Lopina0I. Dmytrenko1D. Lopin2D. Hamov3I. Dyagil4LLC “MED INFORM GROUP”, Kharkiv, Ukraine; Corresponding author.National Scientific Center of Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Department of Radiation Oncohematology and Stem Cell Transplantation, Kyiv, UkraineSI “V. T. Zaitsev Institite of General and Urgent Surgery of NAMS of Ukraine”, Kyiv, Ukraine“Cherkasy Regional Oncology Dispensary” of Cherkasy Regional Council, Regional Medical Hematology Center, Cherkasy, UkraineNational Scientific Center of Radiation Medicine of the National Academy of Medical Sciences of Ukraine, Department of Radiation Oncohematology and Stem Cell Transplantation, Kyiv, Ukrainehttp://www.sciencedirect.com/science/article/pii/S2531137920301668
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	N. Lopina I. Dmytrenko D. Lopin D. Hamov I. Dyagil
spellingShingle	N. Lopina I. Dmytrenko D. Lopin D. Hamov I. Dyagil Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors Hematology, Transfusion and Cell Therapy
author_facet	N. Lopina I. Dmytrenko D. Lopin D. Hamov I. Dyagil
author_sort	N. Lopina
title	Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
title_short	Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
title_full	Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
title_fullStr	Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
title_full_unstemmed	Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
title_sort	cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
publisher	Elsevier
series	Hematology, Transfusion and Cell Therapy
issn	2531-1379
publishDate	2020-10-01
url	http://www.sciencedirect.com/science/article/pii/S2531137920301668
work_keys_str_mv	AT nlopina cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT idmytrenko cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT dlopin cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT dhamov cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors AT idyagil cardiovascularriskreductioninchronicmyeloidleukemiapatientstreatedwiththetyrosinekinaseinhibitors
_version_	1724459865756139520

Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors

Similar Items